The treatment of neurotic and psychotic anxiety with lorazepam.
D000284:Administration, Oral; D000328:Adult; D000374:Aggression / Q000188:drug therapy; D000856:Anorexia Nervosa / Q000188:drug therapy; D001008:Anxiety Disorders / Q000188:drug therapy*; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced
D001570:Benzodiazepinones; D002722:Chlorobenzenes; D014149:Tranquilizing Agents